Advanced search
Publication Cover
Emerging Microbes & Infections Volume 8, 2019 - Issue 1
Submit an article Journal homepage
1,810
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques

Xi Yanga University of Chinese Academy of Sciences, Beijing, People’s Republic of China;b Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Xiang Wangb Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Yufeng Songc Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaView further author information
,
Ping Zhoua University of Chinese Academy of Sciences, Beijing, People’s Republic of China;b Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Dapeng Lia University of Chinese Academy of Sciences, Beijing, People’s Republic of China;b Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Chao Zhanga University of Chinese Academy of Sciences, Beijing, People’s Republic of China;b Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Xia Jina University of Chinese Academy of Sciences, Beijing, People’s Republic of China;b Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Zhong Huanga University of Chinese Academy of Sciences, Beijing, People’s Republic of China;b Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
&
Dongming Zhoua University of Chinese Academy of Sciences, Beijing, People’s Republic of China;b Vaccine Research Center, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People’s Republic of China;d Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1086-1097 | Received 09 Mar 2019, Accepted 11 Jul 2019, Published online: 24 Jul 2019

Related Research Data

An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques.
Source: Informa UK Limited
VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain
Source: American Association for the Advancement of Science (AAAS)
Ebola virus: from discovery to vaccine
Source: Springer Science and Business Media LLC
Ebola vaccines in clinical trial: The promising candidates.
Source: Informa UK Limited
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates
Source: Springer Science and Business Media LLC
Vesicular Stomatitis Virus–Based Ebola Vaccines With Improved Cross-Protective Efficacy
Source: Oxford University Press (OUP)
Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection
Source: Oxford University Press (OUP)
Pathogenicity Comparison Between the Kikwit and Makona Ebola Virus Variants in Rhesus Macaques
Source: Oxford University Press (OUP)
VIRAL HÆMORRHAGIC FEVER IN SOUTHERN SUDAN AND NORTHERN ZAIRE: Preliminary Studies on the Aetiological Agent
Source: Elsevier BV
Chimpanzee adenovirus vaccine protects against Zaire Ebola virus.
Source: Elsevier BV
Chimpanzee-origin adenovirus vectors as vaccine carriers.
Source: Springer Science and Business Media LLC
Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain.
Source: Centers for Disease Control and Prevention (CDC)
Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates
Source: American Association for the Advancement of Science (AAAS)
Rapid, Efficient, and Modular Generation of Adenoviral Vectors via Isothermal Assembly
Source: Wiley
Downregulation of β1 Integrins by Ebola Virus Glycoprotein: Implication for Virus Entry
Source: Elsevier BV
Emergence of Zaire Ebola Virus Disease in Guinea
Source: Massachusetts Medical Society
A heterologous prime-boost Ebola virus vaccine regimen induces durable neutralizing antibody response and prevents Ebola virus-like particle entry in mice
Source: Elsevier BV
An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions.
Source: American Society for Microbiology
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Source: Springer Science and Business Media LLC
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report
Source: Massachusetts Medical Society
Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb
Source: Springer Science and Business Media LLC
Adenoviruses as Vaccine Vectors
Source: Elsevier BV
Chimpanzee Adenovirus Vector Ebola Vaccine
Source: Massachusetts Medical Society
Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
Source: Wiley
Differences in the Comparative Stability of Ebola Virus Makona-C05 and Yambuku-Mayinga in Blood
Source: Public Library of Science (PLoS)
Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques
Source: Taylor & Francis
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
Source: Elsevier BV

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.